|
Volumn 37, Issue 3, 1998, Pages 282-286
|
Use of mycophenolate mofetil for prevention of acute rejection in renal transplantation;Mycophenolate mofetil (MMF) zur prophylaxe yon nierentransplantatabstossungen. Ein neues immunsuppressivum
a a a |
Author keywords
Anti rejection treatment; Immunosuppressive therapy; Multicenter trial; Mycophenolate mofetil
|
Indexed keywords
AZATHIOPRINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
ADULT;
AZATHIOPRINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
TREATMENT OUTCOME;
|
EID: 0031803886
PISSN: 03402592
EISSN: None
Source Type: Journal
DOI: 10.1007/s001200050185 Document Type: Article |
Times cited : (3)
|
References (7)
|